156 related articles for article (PubMed ID: 24613742)
21. [Treatment strategy for patients with multiple liver metastases of colorectal origin in the era of adjuvant chemotherapy].
Seyama Y; Matsuda M; Nishikawa T; Tani K; Inada K; Nasu K; Wada I; Maeshiro T; Miyamoto S; Umekita N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1659-61. PubMed ID: 24393880
[TBL] [Abstract][Full Text] [Related]
22. Portal vein occlusion before major hepatectomy in patients with colorectal liver metastases: rationale, indications, technical aspects, complications and outcome.
Lim C; Farges O
J Visc Surg; 2012 Apr; 149(2):e86-96. PubMed ID: 22504072
[TBL] [Abstract][Full Text] [Related]
23. Liver metastases from colorectal cancer: technique of liver resection.
Heinrich S; Lang H
J Surg Oncol; 2013 May; 107(6):579-84. PubMed ID: 22566374
[TBL] [Abstract][Full Text] [Related]
24. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
Morris-Stiff G; Tan YM; Vauthey JN
Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
[TBL] [Abstract][Full Text] [Related]
25. Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
Nalbantoglu IL; Tan BR; Linehan DC; Gao F; Brunt EM
J Dig Dis; 2014 Oct; 15(10):553-60. PubMed ID: 25060628
[TBL] [Abstract][Full Text] [Related]
26. [Non-cirrhotic portal hypertension presented by acute upper gastrointestinal bleeding 7 years after oxaliplatin-chemotherapy].
Schwarz S; Suppan M; Höbling W; Grünberger A; Nömeyer R; Hubner D; Knoflach P
Z Gastroenterol; 2014 Jul; 52(7):654-6. PubMed ID: 25026007
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma].
Mammano E; Pilati P; Tessari E; Cosci M; Mocellin S; Nitti D
Minerva Chir; 2009 Oct; 64(5):457-63. PubMed ID: 19859036
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
[TBL] [Abstract][Full Text] [Related]
30. Locoregional strategies for colorectal hepatic metastases.
Meyers MO; Sasson AR; Sigurdson ER
Clin Colorectal Cancer; 2003 May; 3(1):34-44. PubMed ID: 12777190
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
[TBL] [Abstract][Full Text] [Related]
32. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.
Pulitanò C; Aldrighetti L; Arru M; Vitali G; Ronzoni M; Catena M; Finazzi R; Villa E; Ferla G
Ann Surg; 2006 Nov; 244(5):833-5; author reply 835. PubMed ID: 17060779
[No Abstract] [Full Text] [Related]
33. [Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].
Kudo D; Tsutsumi S; Akasaka H; Jin H; Ohashi T; Muroya T; Hasebe T; Sakamoto Y; Ishido K; Koyama M; Toyoki Y; Murata A; Narumi S; Kijima H; Hakamada K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2025-7. PubMed ID: 20037312
[TBL] [Abstract][Full Text] [Related]
34. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S
Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091
[TBL] [Abstract][Full Text] [Related]
35. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
[TBL] [Abstract][Full Text] [Related]
36. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
[TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.
Fiorentini G; Rossi S; Dentico P; Meucci F; Bonechi F; Bernardeschi P; Cantore M; Guadagni S; De Simone M
Anticancer Res; 2004; 24(3b):2093-6. PubMed ID: 15274406
[TBL] [Abstract][Full Text] [Related]
38. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
[TBL] [Abstract][Full Text] [Related]
39. [Combined surgical and oncological management of colorectal liver metastases].
Bergenfeldt M; Jensen BV
Ugeskr Laeger; 2008 Apr; 170(16):1353-6. PubMed ID: 18433598
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]